Search results
Showing 1 to 2 of 2 results for agomelatine
Agomelatine for the treatment of major depressive episodes (terminated appraisal) (TA231)
NICE is unable to recommend the use in the NHS of agomelatine for the treatment of major depressive episodes because no evidence submission was received from the manufacturer or sponsor of the technology.
Show all sections
Sections for TA231
Evidence-based recommendations on vortioxetine (Brintellix) for treating major depressive episodes in adults.